Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3AB-OS |
Human osteocarsoma cancer stem cell line | Human | unknown | stem cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | R. di Tiore et al., Bone, 2014, 60: 198-212, doi.org/10.1016/j.bone.2013.12.021 | |||
3AB-OS |
Human osteocarsoma cancer stem cell line | Human | unknown | stem cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M. Marcatti, PhD Thesis, 2015, University of Palermo | Link | ||
48BR |
Human primary fibroblasts | Human | unknown | primary cell | siRNA | RNA-Interference | Metafectene PRO | publication | H. Brunton et al., Mol. Cell. Biol., Oct 2011; 31: 4022 - 4035 | Link | |||
55.1 |
Human immortalized cord blood | Human | immune system | cell line | suspension | plasmid | Metafectene PRO | application note | ![]() |
||||
55.2 |
Human immortalized cord blood | ATCC CRL-2155 | Human | immune system | cell line | suspension | plasmid | Metafectene PRO | application note | ![]() |
|||
5637 |
Human urinary bladder grade II carcinome cell line | ATCC HTB-9 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | J. Mani et al., Maniet al. BMC Cancer, 2015, 15:224; DOI: 10.1186/s12885-015-1239-4 | Link | ||
5637 |
Human urinary bladder grade II carcinome cell line | ATCC HTB-9 | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | S. Caprodossi et al., Carcinogenesis, May 2011; 32: 686 - 694 | Link | ||
5637 |
Human urinary bladder grade II carcinome cell line | ATCC HTB-9 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | C. Amantini et al., Oncotarget, 2016, 7(31): 50180-50194 | Link | |
6E4 HeLaT |
Human cervix adenocarcinoma cell line (derivative of HeLa) | Human | genital tract | cell line | adherent | sgRNA | CRISPR | Metafectene | publication | D. Kim et al., Nat ure Struct ural & Molec ular Biology, 2020, 27: 581–588, doi.org/10.1038/s41594-020-0427-3 | |||
6E4 HeLaT |
Human cervix adenocarcinoma cell line (derivative of HeLa) | Human | genital tract | cell line | adherent | plasmid | CRISPR | Metafectene | publication | D. Kim et al., Nat ure Struct ural & Molec ular Biology, 2020, 27: 581–588, doi.org/10.1038/s41594-020-0427-3 | |||
6E4 HeLaT |
Human cervix adenocarcinoma cell line (derivative of HeLa) | Human | genital tract | cell line | adherent | sgRNA | cotransfection (plasmid/sgRNA) | Metafectene | publication | D. Kim et al., Nat ure Struct ural & Molec ular Biology, 2020, 27: 581–588, doi.org/10.1038/s41594-020-0427-3 | |||
6E4 HeLaT |
Human cervix adenocarcinoma cell line (derivative of HeLa) | Human | genital tract | cell line | adherent | plasmid | cotransfection (plasmid/sgRNA) | Metafectene | publication | D. Kim et al., Nat ure Struct ural & Molec ular Biology, 2020, 27: 581–588, doi.org/10.1038/s41594-020-0427-3 | |||
786-O |
Human renal adenocarcinoma cell line | ATCC CRL-1932 | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | E. Alcaraz, Dissertation, 2015, University of Barcelona | |||
786-O |
Human renal adenocarcinoma cell line | ATCC CRL-1932 | Human | urinary system | cell line | adherent | oligonucleotide | DOTAP | publication | A. Avinó et al., Protocols in Nucleic Acid Chemistry, 2020, 77: e78, doi: 10.1002/cpnc.78 | |||
786-O |
Human renal adenocarcinoma cell line | ATCC CRL-1932 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | E. Alcaraz, Dissertation, 2015, University of Barcelona | ||
8505C |
Human papillary thyroid cancer cell line | Human | other | cell line | adherent | plasmid | Metafectene PRO | publication | V. Vella et al., Endocrine-Related Cancer, 2019, 197–214, 26: 1, doi.org/10.1530/ERC-18-0310 | Link | |||
8VM |
Human primary glioma cells | Human | nervous system | primary cell | plasmid | Metafectene PRO | application note | ![]() |
|||||
92.1 |
Human uveal melanoma cell line | Human | skin | cell line | adherent | plasmid | Metafectene PRO | publication | I. Venza et al., Int. Immunopharmacol., 2014, 21: 439–446; doi.org/10.1016/j.intimp.2014.05.024 | ||||
92.1 |
Human uveal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M. Venza et al., Biochem. and Biophys. Res. Commun., 2013, 441: 743–750, doi.org/10.1016/j.bbrc.2013.10.114 | |||
92.1 |
Human uveal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | I. Venza et al., Int. Immunopharmacol., 2014, 21: 439–446; doi.org/10.1016/j.intimp.2014.05.024 | |||
A-2058 |
Human skin melanoma cell line | ATCC CRL-11147 | Human | skin | cell line | adherent | plasmid | Metafectene | publication | E. Cesaro et al., Research Square, 2021, DOI: https://doi.org/10.21203/rs.3.rs-278700/v1 | Link | ||
A-2058 |
Human skin melanoma cell line | ATCC CRL-11147 | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | F. Albano et al., Biochimie, 2012, DOI: 10.1016/j.biochi.2012.12.012 | ||
A-2058 |
Human skin melanoma cell line | ATCC CRL-11147 | Human | skin | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | E. Cesaro et al., Research Square, 2021, DOI: https://doi.org/10.21203/rs.3.rs-278700/v1 | Link | |
A-2058 |
Human skin melanoma cell line | ATCC CRL-11147 | Human | skin | cell line | adherent | plasmid | K2 Transfection System | application note | ![]() |
|||
A-2780 |
Human ovarian carcinoma cell line | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | K4 Transfection System | application note | ![]() |